Raziskovanje detranzicije je novo področje. Hiter porast diagnoz spolnega nelagodja v zadnjem desetletju – zlasti med najstnicami – je ustvaril rastočo populacijo detranzicionarjev, čeprav zbiranje podatkov ostaja izziv zaradi velikega odstopanja pri nadaljnjem spremljanju, ideološke razdeljenosti in metodoloških omejitev.
Psihiatrična obolevnost med mladostniki in mladimi odraslimi, ki so se obrnili na specializirane storitve za spolno identiteto na Finskem v letih 1996–2019: Registrska študija(2026)
Ruuska et al.
mental healthcohort studytransition outcomesdiagnostic trends
Finska nacionalna kohortna študija 2 083 posameznikov, mlajših od 23 let, napotenih zaradi spolne identitete (1996–2019), v primerjavi s 16 643 ujemajočimi se kontrolami. Mladostniki, napoteni zaradi spolne identitete, so pokazali bistveno višjo psihiatrično obolevnost od kontrol tako pred (45,7 % v primerjavi s 15,0 %) kot ≥2 leti po napotitvi (61,7 % v primerjavi s 14,6 %). Tisti, napoteni po letu 2010, so imeli večje psihiatrične potrebe kot prejšnje kohorte. Med mladostniki, ki so prestali medicinsko spremembo spola, se je psihiatrična obolevnost med spremljanjem bistveno povečala – z 9,8 % na 60,7 % pri feminizirajoči spremembi spola in z 21,6 % na 54,5 % pri maskulinizirajoči spremembi spola. Po prilagoditvi za predhodno psihiatrično zdravljenje so imeli vsi mladostniki, napoteni zaradi spolne identitete, podobno povečana tveganja za psihiatrično obolevnost, z razmerji tveganja približno trikrat višjimi kot pri ženskih kontrolah in petkrat višjimi kot pri moških kontrolah. Zaključuje, da je huda psihiatrična obolevnost pogosta med mladostniki, napotenimi zaradi spolne identitete, se zdi pogostejša pri tistih, napotenih po nedavnem porastu napotitev, in psihiatrične potrebe ne pojenjajo po medicinski spremembi spola.
onlinelibrary.wiley.com/doi/10.1111/apa.70533Key Findings
- Far higher psychiatric morbidity: Gender-referred adolescents were about three times more likely to have received specialist psychiatric treatment before referral compared to matched controls, and this gap widened after referral.
- Post-2010 surge linked to greater needs: Youth referred after 2010 showed roughly double the pre-referral psychiatric morbidity of the earlier cohort, suggesting increasingly complex cases.
- Psychiatric needs increased after medical transition: Among those who underwent medical gender reassignment, the proportion needing specialist psychiatric care rose sharply during follow-up—especially among those receiving feminising treatment (from ~10% to ~61%).
- Risk remains elevated even after accounting for prior mental health: After adjusting for pre-existing psychiatric treatment, all gender-referred groups still had a 3- to 5-fold higher risk of severe psychiatric morbidity than controls, regardless of whether they underwent medical transition.
- Clinical takeaway: The findings emphasize the need for thorough psychiatric evaluation and continuous mental health support before, during, and after any medical gender reassignment, as psychiatric needs often persist or worsen rather than resolve.
Potek zdravljenja med otroki in mladostniki, napotjenimi v Norveški nacionalni center za spolno neskladnost(2025)
Cecilie Bjertness Nyquist, Leila Torgersen, Linda W. David, Trond Haaken Diseth, Kjersti Gulbrandsen, Anne Waehre (Acta Paediatrica)
cohort studytransition outcomesdetransitionpuberty suppression
Ta norveška kohortna študija 1.258 mladih, napotjenih v Nacionalni center za spolno neskladnost, je pokazala, da je bilo 22 % odpuščenih brez zdravljenja, ki potrjuje spol. Od tistih, ki so začeli s testosteronom, je 18 žensk detransicioniralo (11 zaradi prenehanja transspolne identitete). Študija poudarja visoko stopnjo nadaljevanja od zaviralcev pubertete do hormonov (97 %), kar vzbuja zaskrbljenost glede učinka cevovoda, in poudarja potrebo po dolgoročnem spremljanju glede na različne poti zdravljenja, vključno z detransicijo.
pubmed.ncbi.nlm.nih.gov/39648282/Key Findings
- Among 1,258 children and adolescents referred to Norway's national gender clinic from 2000-2020, 62% started gender-affirming hormone treatment (GAHT) and 11% received puberty blockers (GnRHa).
- Nearly all (97%) of those who received puberty blockers went on to hormone treatment, raising questions about whether blockers allow for meaningful exploration of gender identity.
- Eighteen individuals assigned female at birth (2.3% of those on GAHT) detransitioned after testosterone treatment, with most ceasing to identify as transgender entirely.
- Because of loss to follow-up and incomplete external treatment data, the authors acknowledge their detransition figure (2.3% of those who started GAHT) may be too low. They cite a Finnish nationwide register study finding a 7.9% discontinuation rate to support the concern that their number is probably an underestimate.
- About 22% of those who attended at least one appointment were discharged without any medical treatment, most commonly due to mental health concerns.
- The study highlights significant shifts in Norwegian clinical practice over time, with declining use of puberty blockers in recent years amid growing international scrutiny of evidence for these treatments.
Epidemiologija spolne disforije in spolne neskladnosti pri otrocih in mladostnikih, ki obiskujejo primarno zdravstveno oskrbo v Angliji: retrospektivna kohortna študija(2025)
Jarvis et al.
mental healthcohort studydiagnostic trends
Ta obsežna študija angleških evidenc primarnega zdravstvenega varstva je odkrila 50-kratno (5000%) povečanje zabeležene spolne disforije/neskladja pri otrocih in mladostnikih, starih 0-18 let, med letoma 2011 in 2021. Prevalenca se je povečala z 0,16 na 8,3 na 10.000 oseb, pri čemer je bilo povečanje najbolj izrazito pri rojstno registriranih ženskah po letu 2014. Študija je prav tako odkrila visoko stopnjo sočasnih duševnih zdravstvenih težav - 52,7 % je imelo evidence anksioznosti, depresije ali samopoškodovanja. Medicinski posegi so bili razmeroma redki, pri čemer je bilo 4,7 % predpisanih zaviralcev pubertete in 8,0 % predpisanih križnih spolnih hormonov. Avtorji opozarjajo na nujno potrebo po boljši podpori duševnega zdravja za to populacijo.
pmc.ncbi.nlm.nih.gov/articles/PMC12320607/Key Findings
- A 50-fold increase in recorded diagnoses
- Between 2011 and 2021, the recorded prevalence of gender dysphoria/incongruence in English primary care rose from roughly 1 in 60,000 to about 1 in 1,200 among 17–18 year olds.
- The rise is driven mainly by recorded females
- After 2014, incidence increased far more rapidly in females than males; by 2021, prevalence was approximately twice as high in females, reversing historical patterns.
- Mental health co-conditions are very common
- Over half (52.7%) of affected children and young people had a record of anxiety, depression, or self-harm—substantially higher than matched youth with autism or eating disorders, especially for depression and self-harm.
- Medical hormone treatment remains rare in primary care records
- Only 4.7% received puberty-suppressing hormones and 8.0% received masculinising/feminising hormones, likely reflecting long specialist waiting times and under-recording of treatments initiated elsewhere.
- Strongly age-linked, but not deprivation-linked
- Cases were rarely recorded before age 11 and peaked at ages 17–18; there was no consistent association between prevalence and neighbourhood deprivation levels.
Zaviralci pubertete za spolno disforijo pri mladih: Sistematični pregled in meta-analiza(2025)
Anna Miroshnychenko, Yetiani Roldan, Sara Ibrahim, Chan Kulatunga-Moruzi, Steven Montante, Rachel Couban, Gordon Guyatt, Romina Brignardello-Petersen (Archives of Disease in Childhood)
mental healthcohort studypuberty suppressionmedical ethicsgender dysphoria
Ta sistematični pregled in meta-analiza iz Archives of Disease in Childhood je preučil 10 študij o zaviralcih pubertete za mlade s spolno disforijo. Avtorji so ugotovili "precejšnjo negotovost glede učinkov zaviralcev pubertete" z dokazi o "zelo nizki gotovosti" za rezultate, vključno z globalno funkcijo, depresijo in gostoto kostnih mineralov. Primerjalne opazovalne študije so zagotovile dokaze z zelo nizko gotovostjo, študije pred in po pa so prav tako pokazale zelo nizko gotovost. Avtorji sklepajo, da so "potrebne metodološko stroge prospektivne študije", prej kot lahko te intervencije zaupno priporočimo.
pubmed.ncbi.nlm.nih.gov/39855724/Key Findings
- The evidence for puberty blockers' effects on youth with gender dysphoria is mostly 'very low certainty' across all measured outcomes, meaning we cannot reliably conclude whether they help or harm.
- Only 10 studies met inclusion criteria, with no randomized controlled trials found; most studies had serious methodological flaws like missing data and lack of proper comparison groups.
- Potential mental health benefits (improved global function, reduced depression and gender dysphoria) were suggested but remain highly uncertain due to weak study designs. Another study (Olson-Kennedy et al., 2025) shows that depression got worse.
- Bone mineral density at the hip, spine, and femoral neck appeared lower after puberty blocker use, though this finding also carries very low certainty.
- The authors call for methodologically rigorous prospective studies and possibly randomized controlled trials to better understand both short-term and long-term effects of this intervention.
Spolno potrditvena hormonska terapija za posameznike s spolno disforijo, stare <26 let: sistematični pregled in meta-analiza(2025)
Anna Miroshnychenko, Sara Ibrahim, Yetiani Roldan, Chan Kulatunga-Moruzi, Steven Montante, Rachel Couban, Gordon Guyatt, Romina Brignardello-Petersen (Archives of Disease in Childhood)
mental healthcohort studypuberty suppressionmedical ethicsgender dysphoriasystematic reviewmeta-analysis
Ta izčrpni sistematični pregled in meta-analiza sta ovrednotila 24 študij o spolno potrditveni hormonski terapiji (GAHT) za posameznike, mlajše od 26 let. Pregled je večinoma našel dokaze z "zelo nizko gotovostjo" v zvezi s spolno disforijo, globalno funkcijo in depresijo. Čeprav je ena študija nakazala manjše možnosti za depresijo (OR 0,73), je bila to ocenjena kot dokaz z nizko gotovostjo. Avtorji so zaključili: "Obstaja precejšnja negotovost glede učinkov GAHT in ne moremo izključiti možnosti koristi ali škode. Potrebne so metodološko stroge prospektivne študije za ustvarjanje dokazov z večjo gotovostjo."
pubmed.ncbi.nlm.nih.gov/39855725/Key Findings
- The evidence for most effects of gender affirming hormone therapy (GAHT) in young people under 26 is very low certainty, meaning we cannot confidently determine benefits or harms.
- Only one study found low certainty evidence that depression may be lower in those who received GAHT compared to those who did not.
- Cardiovascular events were the only outcomes with higher certainty evidence: about 4% of natal females experienced cardiovascular events 7-109 months after GAHT (high certainty), and about 0.2% at 26 months (moderate certainty).
- All 24 included studies had serious methodological limitations, including failure to adjust for important confounders like mental health conditions, missing data, and participants receiving other treatments.
- The authors conclude that better designed prospective studies are urgently needed to understand the true effects of GAHT on gender dysphoria, mental health, bone density, and other outcomes.
Ali želimo vedeti?(2025)
D'Angelo, R. (The International Journal of Psychoanalysis)
detransitiontraumagender exploratory therapycountertransferencemedical ethics
Ta članek trdi, da šibka dokazna podlaga in globoke posledice spolnih potrditvenih posegov za mlade zahtevajo občutljivo psihoanalitično raziskovanje. Kritizira, kako družbeno-politični trendi postavljajo globoko raziskovanje razlogov, zakaj mladi iščejo zdravstveni prehod, kot 'prepovedano' ali kot terapijo spreobrnjenja. Avtor ugotavlja, da politično motivirani kliniki napačno predstavljajo tiste, ki raziskujejo pomen trans identifikacije, zmanjšujejo šibko dokazno podlago in resne tveganja, medtem ko prikrivajo psihično bolečino pod spolno disforijo.
pubmed.ncbi.nlm.nih.gov/39327914/Key Findings
- Trauma can hide behind a fixed trans narrative. In the case of Elly, a history of maternal abuse and emotional neglect only emerged after 18 months of analytic work, revealing her gender dysphoria was deeply entangled with unprocessed psychic pain that brief clinic assessments would never have uncovered.
- The medical evidence base is shaky. Systematic reviews from the UK (Cass Review), Sweden, Finland and Germany consistently find that evidence for the benefits of puberty blockers and cross-sex hormones in youth is of very low quality, while serious physical harms—including cardiovascular risks and infertility—are well established.
- There is a "prohibition on knowing" at every level. Patients like Elly fiercely defend against exploration of their gendered experience, and this individual resistance is reinforced by a socio-political climate that frames any questioning of trans identity as transphobic or a form of conversion therapy.
- Advocacy within psychoanalysis is misrepresenting exploratory work. Prominent analysts who promote medical affirmation are, in D'Angelo's view, distorting the intent of clinicians who ask "why," erasing the suffering of detransitioners, and abandoning the analytic mandate to understand unconscious meaning.
- The profession may be over-correcting for its past. The analytic community's defensive rush to affirm medical transition may be driven by unconscious guilt over its history of pathologising homosexuality, coupled with clinicians avoiding the dread and helplessness that arise when sitting with a young person pursuing irreversible body modification.
Pripovedi odraslih, registriranih kot ženske ob rojstvu, ki so začeli medicinsko tranzicijo in se kasneje detranzicionirali(2025)
Jane Lomax, Catherine Butler (Archives of Sexual Behavior)
mental healthdetransitionnarrative analysisgender dysphoriaqualitative researchautism
Kvalitativna študija šestih britanskih žensk (starosti 21-32 let), ki so se detranzicionirale po medicinskih posegih. Pojavile so se štiri narativne teme: omejitve medicinske tranzicije pri reševanju disforije, dolgoročne zdravstvene skrbi glede testosterona, družbeni izzivi življenja kot moški in detranzicija kot tekoč proces. Udeleženke so poročale o neizpolnjenih potrebah po podpori in poudarile pomen realističnih pričakovanj glede rezultatov tranzicije.
link.springer.com/article/10.1007/s10508-025-03083-9#ref-CR61Key Findings
- Medical transition had limits: Participants found that hormones and surgery did not fully resolve their gender dysphoria or underlying mental health struggles, with some experiencing intensified distress or 'reverse dysphoria' after physical changes.
- Long-term health concerns drove decisions: Anxiety about unknown long-term effects of testosterone on female bodies—such as cardiovascular risks, uterine atrophy, and infertility—contributed to detransition, with participants feeling inadequately informed beforehand.
- Social belonging shifted over time: Many discovered they felt more authentic connecting with women and lesbian communities rather than living as men, with some realizing narrow stereotypes of womanhood had influenced their initial decision to transition.
- Detransition is complex and ongoing: The process involved grief, guilt, and practical challenges like navigating a masculinized appearance, with most finding alternative ways to manage distress rather than through medical intervention.
- Support systems are largely inadequate: Participants reported unmet needs from healthcare providers and therapists, often turning to online detransition communities for information, practical guidance, and emotional support instead.
Spolna disforija in detranzicija pri odraslih: Analiza devetih pacientov iz klinike za spolno identiteto na Finskem(2025)
Kaisa Kettula, Niina Puustinen, Lotta Tynkkynen, Liisa Lempinen, Katinka Tuisku (Archives of Sexual Behavior)
mental healthcohort studydetransitiontraumamedical ethicsgender dysphoria
Ta finska študija devetih detranzicionerjev (7 žensk, 2 moških) je ugotovila, da so vsi poročali, da njihov začetni prehod ni bil motiviran z resnično transspolno identiteto, temveč z nerešenimi psihološkimi stresorji, vključno z otroškimi travmami, spolnim zlorabljanjem, motnjami hranjenja in simptomi mejne osebnosti. Vseh sedem žensk je imelo 'veliko' obžalovanja s povprečnim časom obžalovanja 7 let. Retrospektivno so bolniki ugotovili, da je potreba po prehodu izvirala iz izzivov zorenja in težav s povezovanjem, ne iz spolne disforije. Študija poudarja ključni pomen temeljite psihološke ocene pred zdravstvenim posegom.
pubmed.ncbi.nlm.nih.gov/40394447/Key Findings
- This study of nine Finnish adults who detransitioned found that most (seven of nine) experienced 'major regret' and sought to reverse their gender-affirming treatments, with an average of seven years passing before regret emerged.
- The detransitioners had very high rates of psychiatric conditions, including mood disorders (89%), anxiety disorders (78%), borderline personality disorder (56%), eating disorders or symptoms (78%), and childhood trauma or sexual abuse affecting nearly all patients.
- Patients retrospectively reported that their original desire to transition stemmed not from true transgender identity, but from factors like trauma, misogyny, dissociative disorders, difficult life circumstances, or confusion about sexuality.
- The clinic made several practice changes in response, including removing referral requirements for detransitioners, increasing psychiatric collaboration, offering psychotherapy, and emphasizing professional neutrality rather than affirmation.
- The authors stress that thorough psychological evaluation—especially for trauma, dissociation, and attachment issues—should precede irreversible interventions to reduce adverse outcomes.
Vpliv zaviralcev pubertete in staranja na stanja in delovanje testikularnih celic(2024)
Murugesh et al
puberty supressioninfertility
Analiza dečkov, ki jemljejo zaviralce pubertete, kaže trajno poškodbo spermatogonialnih matičnih celic, kar nakazuje ireverzibilno neplodnost tudi po prenehanju.
pubmed.ncbi.nlm.nih.gov/38585884/Key Findings
- Widespread use, limited data — 100% of gender dysphoria patients in this pediatric biorepository were on puberty blockers, yet long-term effects on testicular development remain poorly understood.
- Physical atrophy observed — Histology revealed mild-to-severe seminiferous tubule atrophy in PB-treated children, with some patients showing fully atrophied glands and microlithiasis.
- Developmental block at stem cell stage — Single-cell analysis showed >90% of germ cells in PB-treated juveniles were arrested at the spermatogonial stage, failing to progress toward meiosis.
- Machine learning flags "prepubertal" profile — Models trained on normal developmental data classified PB-treated patients as prepubertal across all cell types, suggesting incomplete or absent maturation of the testicular niche.
- Reversibility questioned — The combination of gland atrophy, abnormal cell proportions, and persistently immature gene expression signatures raises concerns about whether complete reproductive recovery is guaranteed after discontinuing puberty blockers.
Tveganje samomora in samopoškodbe po spolno potrditveni operaciji(2024)
John J. Straub, Krishna K. Paul, Lauren G. Bothwell, Sterling J. Deshazo, Georgiy Golovko, Michael S. Miller, Dietrich V. Jehle (Cureus)
mental healthcohort studydiagnostic trendstraumamedical ethicsgender dysphoriasurgeries
Retrospektivna študija z uporabo baze podatkov TriNetX (56 zdravstvenih organizacij v ZDA, več kot 90 milijonov bolnikov), ki je preučevala tveganje za samomor in samopoškodbo po spolno-potrditveni operaciji. Študija je primerjala 1.501 odraslih, ki so imeli spolno-potrditveno operacijo in obiske na urgenci, s kontrolnimi skupinami. Glavne ugotovitve: posamezniki, ki so bili deležni spolno-potrditvene operacije, so imeli 12,12-krat večje tveganje za poskus samomora kot tisti brez operacije (3,47 % v primerjavi z 0,29 %); v primerjavi s kontrolno skupino s tubalno ligacijo/vazektomijo je bilo tveganje pred upravljanjem s propensity matchingom 5,03-krat večje, po ujemanju pa 4,71-krat večje (3,50 % v primerjavi z 0,74 %); rezultati so bili konsistentni tudi ob uporabi kontrolne skupine s faringitisom. Študija zaključuje, da bolniki, ki so bili deležni spolno-potrditvene operacije, kažejo bistveno povišano tveganje za samomor, kar poudarja potrebo po celoviti psihiatrični podpori po posegu.
pmc.ncbi.nlm.nih.gov/articles/PMC11063965/Key Findings
- Patients who underwent gender-affirming surgery had a 12.12 times higher risk of suicide attempts compared to general emergency department patients, and a 4.71 times higher risk compared to patients who had tubal ligation or vasectomy procedures.
- The study found significantly elevated risks across all measured outcomes: suicide attempts, death, self-harm, and PTSD—persisting even after propensity matching for age, race, ethnicity, and sex.
- PTSD risk was notably elevated, with a 7.76-fold increase compared to general emergency patients and 3.23-fold increase after matching with surgical controls, suggesting pre-operative trauma and post-operative challenges both play important roles.
- The large-scale retrospective study used real-world data from over 90 million patients across 56 U.S. healthcare organizations over a 20-year period, making it one of the largest studies of its kind.
- The authors emphasize that their findings show association rather than causation, and conclude that comprehensive psychiatric support and mental health care are essential in the years following gender-affirming surgery.
Pregled Cass(2024)
Hilary Cass (The Cass Review)
mental healthtransition outcomespuberty suppressionmedical ethicsgender dysphoriaautismsystematic review
Neodvisen sistematičen pregled, ki ga je naročil NHS England v Združenem kraljestvu, ocenjuje več kot 100 študij o storitvah spolne identitete za mlade pod 18 let. Predstavlja visoko stopnjo kritike afirmativnih modelov oskrbe, poudarjajoč metodološke pomanjkljivosti v obstoječih raziskavah. Ugotovil je, da so dokazi za zaviralce pubertete in križne spolne hormone "izjemno šibki" ali nizke kakovosti, manjkajo randomizirane študije, s tveganji, kot je izguba gostote kosti in negotove koristi za duševno zdravje.
https://segm.org/Final-Cass-Report-2024-NHS-Response-SummaryKey Findings
- The review emphasizes evidence-based, holistic care for gender-questioning youth rather than a social justice model, calling for individualized assessments that screen for co-occurring conditions like autism and mental health issues.
- The evidence base for medical interventions—particularly puberty blockers and hormones—was found to be weak, prompting recommendations for a full research program and extreme caution, especially for hormones starting at age 16.
- A nominated medical practitioner should take overall clinical responsibility for patient safety, and every case for medical treatment must be reviewed by a national multidisciplinary team.
- Social transition decisions for pre-pubertal children should involve early consultation with experienced clinical professionals, reflecting a more cautious approach than previously standard.
- All children being considered for medical pathways must be offered fertility counseling and preservation before starting treatment.
Pogostnost detransicije pri osebah, ki iščejo hormonsko zdravljenje za potrditev spola: sistematični pregled(2024)
Eva Feigerlova (Journal of Sexual Medicine)
cohort studydetransitionpuberty suppressiongender exploratory therapymedical ethicsgender dysphoriasystematic review
Ta sistematični pregled v Journal of Sexual Medicine je preučil obstoječe raziskave o stopnjah detransicije pri posameznikih, ki so zahtevali ali začeli hormonsko zdravljenje za potrditev spola. Pregled je odkril pomembne vrzeli v literaturi in identificiral potencialne vire pristranskosti v različnih nizih podatkov. Avtor ugotavlja, da kljub nedavnim dokazom, ki kažejo na koristi postopkov za potrditev spola, nastajajoče zahteve po detransiciji in poročila o obžalovanju kažejo na kritične vrzeli v znanju. Pregled poudarja potrebo po boljših dolgoročnih nadaljnjih študijah za razumevanje resnične pogostnosti detransicije in njenih osnovnih vzrokov.
pubmed.ncbi.nlm.nih.gov/39724926/Key Findings
- Detransition rates are relatively low: shifts in treatment requests before any medication ranged from 0.8-7.4%, puberty blocker (GnRHa) discontinuation from 1-7.6%, and hormone therapy (GAHT) discontinuation from 1.6-9.8%.
- The 15 included studies were highly heterogeneous and generally low quality—most were retrospective, had insufficient follow-up times, used inconsistent definitions of detransition, and failed to account for confounding factors like social or financial pressures.
- Reasons for stopping treatment varied widely and were not limited to identity changes; they included side effects, financial barriers, social issues, treatment goals being met, and poor compliance, making it difficult to isolate true identity-based detransition.
- There is no standardized definition of detransition across studies, with some counting anyone who stopped identifying as transgender regardless of medical steps taken, while others required actual hormone discontinuation with intent to revert to birth-assigned gender.
- The authors conclude that detransition remains insufficiently studied and call for well-designed long-term prospective research with consistent measurement tools, adequate follow-up, and control for confounding variables to better inform healthcare providers and policymakers.
Kakšen je namen PEDIATRIČNE 'spolno potrjujoče' oskrbe?(2024)
Gorin, M.
mental healthpuberty suppressionmedical ethicsgender dysphoriasystematic reviewautonomygender-affirming care
Objavljeno v poročilu Hastings Center, ta bioetična analiza kritizira premik od utemeljitev na dokazih za pediatrično spolno potrjujočo oskrbo k "avtonomiji temelječim" argumentom, ki se sklicujejo na "cilje utelešenja". Avtor trdi, da so nedavne sistematične preglede ugotovile, da so znanstveni dokazi negotovi, zaradi česar nekateri opustijo izboljšanje zdravja kot cilj in namesto tega upravičujejo posege skozi avtonomijo pacienta. Gorin sklepa, da ti argumenti, ki temeljijo na avtonomiji, napačno razumejo mesto avtonomije v kliničnem odločanju in posledično postavljajo paciente v nevarnost zdravstvene škode.
pubmed.ncbi.nlm.nih.gov/38842886/Key Findings
- Current U.S. clinical guidelines endorse puberty blockers, cross-sex hormones, and surgery for youth gender dysphoria, but international bodies in England, Sweden, and Finland have pulled back after systematic reviews found weak evidence of medical benefits.
- The Dutch protocol—the original research basis for pediatric medical transition—had significant methodological flaws, including no control group, confounded measurement of gender dysphoria, and a population very different from today's patients.
- Some bioethicists argue youth should have a right to transition-related interventions based on 'embodiment goals' and autonomy alone, without requiring evidence of mental health benefits or even a diagnosis.
- The author argues this autonomy-based view contradicts medicine's core principle of nonmaleficence: patient desire for body modification is not sufficient justification for risky medical interventions without evidence of health benefits.
- International discrepancies in treatment guidelines stem partly from different standards of evidence assessment (systematic reviews vs. narrative reviews) and partly from deeper value disagreements about whether medicine's aim is health improvement or fulfilling patient identity goals.
Stopnja detranzicije ni znana(2023)
J. Cohn (Archives of Sexual Behavior)
detransitionpuberty suppressionmedical ethicsgender dysphoriasystematic reviewsurgeriesgender-affirming care
Ta članek trdi, da dejanske stopnje detranzicije, prekinitve in obžalovanja niso znane zaradi pomembnih pomanjkljivosti v obstoječih raziskavah. Kritizira široko citirane študije zaradi težav, kot so kratka obdobja spremljanja (saj lahko obžalovanje traja leta, da se pojavi), visoke stopnje izgube pri spremljanju in uporaba vzorcev, ki ne odražajo nedavnega porasta primerov med mladostniki. Avtor zaključuje, da so trditve o zelo nizkih stopnjah obžalovanja nezanesljive in da je ta negotovost ključnega pomena za informirano privolitev.
link.springer.com/article/10.1007/s10508-023-02623-5Key Findings
- The true rates of detransition, regret, and discontinuation of gender-affirming medical interventions are unknown, despite frequent claims that they are very low (0.3-0.6%).
- Existing studies on regret and detransition suffer from serious methodological flaws: too-short follow-up periods, high loss to follow-up, inadequate measurement instruments, and samples that don't represent today's patient population.
- Observed times to regret or detransition are often long—averaging 3-10+ years—meaning studies with short follow-up periods systematically underestimate true rates.
- The current evidence base for medical interventions for gender dysphoria is of 'low' to 'very low' quality, with no randomized controlled trials comparable to those standard in other fields like depression treatment.
- Young people and families considering medical intervention should be informed that reliable data on risks like regret and detransition are unavailable, as this uncertainty is essential for truly informed consent.
Spremembe v medicinskih zahtevah, povezanih s spolom, pri transspolnih in spolno raznolikih mladostnikih(2023)
Ariel Cohen, Veronica Gomez-Lobo, Laura Willing, David Call, Lauren F. Damle, Lawrence J. D'Angelo, Amber Song, John F. Strang,
transition outcomespuberty suppressiongender dysphoriaqualitative researchautismgender-affirming caremixed-methods
Ta študija 68 mladostnikov na kliniki za spol (47 % avtističnih) je pokazala, da je skoraj tretjina (29 %) spremenila svoje zahteve za medicinski prehod. Spremembe so bile pogostejše pri nebinarni mladini in so bile obravnavane kot 'ne neobičajen' del procesa razločevanja spola. Najpogostejši vzorec je bil umik zahteve in kasnejše nadaljevanje.
https://www.sciencedirect.com/science/article/abs/pii/S1054139X22007194Key Findings
- Nearly one-third (29%) of gender-diverse youth in the study shifted their requests for gender-affirming hormones or surgery over time, suggesting such changes are not uncommon during adolescent gender exploration.
- Nonbinary youth were significantly more likely to experience shifts in medical requests compared to binary transgender youth, though no differences were found by age, autism status, or sex assigned at birth.
- The most common pattern (45% of those with shifts) involved youth making a request, withdrawing it, and later re-requesting treatment—indicating that stepping back from medical requests is often temporary rather than final.
- Most shifts (85%) occurred before any treatment began, and only one participant in the entire study expressed regret after starting treatment, consistent with prior research that regret is rare.
- Key reasons for shifts fell into two main themes: ongoing gender discovery (wanting more time, exploring identity) and interpersonal influences (lack of support, coming-out worries, peer pressure), with mental health clinicians playing a valuable role in supporting youth through this non-linear process.
Prehod nazaj in opustitev spola med prej trans-identificiranimi mladimi odraslimi(2023)
Sasha Ayad, Lisa Marchiano, Kenneth J. Zucker (Archives of Sexual Behavior)
mental healthtransition outcomesdetransitiontraumagender dysphoriaqualitative researchrapid-onset gender dysphoria
Raziskava je zajela 78 mladih odraslih v ZDA (starih 18–33 let), ki so se v preteklosti identificirali kot transseksualci, pa so svojo identiteto spremenili vsaj šest mesecev pred raziskavo. Ugotovljeno je bilo, da je 83 % udeležencev storilo korake družbenega prehoda in 68 % medicinskega prehoda. Glavne ugotovitve: manj kot 17 % je izpolnjevalo DSM-5 kriterije za otroško spolno disforijo, 53 % pa je menilo, da se na njihove primere nanaša koncept hitro nastale spolne disforije; 91 % je bilo rojenih kot dekleta; udeleženci so pred identifikacijo kot trans poročali o visokih stopnjah psihiatričnih diagnoz; psihično zdravje se jim je po preklicu identitete močno izboljšalo, upadla sta samopoškodovanje in spolna disforija; najpogostejši razlog za začetno identifikacijo kot trans je bilo zamenjavanje duševnih težav ali reakcij na travme s spolno disforijo; razlogi za preklic identitete so izhajali iz notranjih sprememb, ne zunanjih pritiskov. Raziskava kaže, da je preklic trans identitete za nekatere posameznike mogoč in koristen.
pmc.ncbi.nlm.nih.gov/articles/PMC10794437/Key Findings
- The vast majority of participants (91%) were natal females, and most reported that their psychological health improved dramatically after detransition, with large decreases in self-harm and gender dysphoria and increases in well-being.
- Fewer than 17% of participants met diagnostic criteria for childhood gender dysphoria, while 53% believed 'rapid-onset gender dysphoria' applied to them—suggesting many developed gender dysphoria suddenly during or after puberty without prior history.
- Participants had very high rates of psychiatric diagnoses (95% had at least one lifetime diagnosis) and self-harm (79%), with most mental health issues predating their transgender identification.
- The most common reason for initial trans-identification was confusing mental health issues or trauma reactions for gender dysphoria; reasons for detransition were primarily internal (own thought processes, realizing causes were more complicated) rather than external pressures like family or discrimination.
- Most participants (68%) had taken medical transition steps including hormones, and 28% had undergone surgery, yet the majority felt inadequately informed about risks and alternatives during the informed consent process.
Jatrogena škoda v spolni medicini(2023)
Sarah C. J. Jorgensen (Journal of Sex & Marital Therapy)
mental healthdetransitiontraumamedical ethicsgender dysphoriagender-affirming careiatrogenic harm
Ta komentar trdi, da 'model spolne potrditve' povzroča jatrogeno škodo, kar dokazuje vse večje število mladih, ki se odločijo za prehod nazaj. Avtor kritizira model zaradi nezadostne psihološke ocene, podcenjevanja medicinskih tveganj in zanašanja na šibke dokaze. Poziva k priznavanju tistih, ki se odločijo za prehod nazaj, kot preživelih medicinske škode, in poziva k odprti razpravi in raziskavam o dolgoročnih učinkih prehoda mladih, pri čemer ugotavlja, da mnoge evropske države zdaj sprejemajo bolj previdne pristope.
www.tandfonline.com/doi/full/10.1080/0092623X.2023.2224320Key Findings
- Growing numbers of young people are detransitioning and experiencing regret over permanent physical changes, suggesting problems with the current gender-affirming care model.
- Recent studies indicate 10-30% of youth who undergo medical transition discontinue treatment within 1-4 years, yet long-term data is virtually nonexistent.
- Mental health issues, trauma, and neurodiversity are often inadequately explored before transition, with 'minority stress' frequently used to explain away complex psychological conditions.
- Major medical guidelines largely ignore detransitioners, leaving them without clinical guidance, support, or proper care for lasting hormonal and surgical effects.
- Several countries are shifting away from medical transition as first-line treatment for youth after systematic reviews found weak evidence supporting these interventions.
Spolna disforija pri mladih narašča – prav tako tudi strokovna nesoglasja(2023)
Jennifer Block (The BMJ)
diagnostic trendsdetransitionpuberty suppressionmedical ethicsgender dysphoriasystematic reviewgender-affirming care
To raziskovalno poročilo poudarja naraščajočo mednarodno razpravo o medicinskem prehodu za mladoletnike. Medtem ko ameriški medicinski organi podpirajo 'spolno potrjevalno oskrbo', več evropskih držav (Švedska, Finska, Združeno kraljestvo) poziva k previdnosti zaradi nizkokakovostnih dokazov. Članek postavlja pod vprašaj trditev o medicinskem soglasju, opozarja na sistematične preglede, ki ugotavljajo, da so dokazi za hormonsko zdravljenje pri mladostnikih 'nizke' ali 'zelo nizke' kakovosti, in opozarja na pomanjkanje podatkov o dolgoročnih rezultatih.
https://www.bmj.com/content/380/bmj.p382Key Findings
- Rising numbers of young people with gender dysphoria are seeking medical treatment, yet professional opinions are deeply divided—US medical groups broadly support 'gender-affirming care' while several European countries are restricting medical interventions for minors due to insufficient evidence.
- Major US medical organizations describe gender-affirming treatments as 'evidence-based,' but independent experts found serious methodological flaws in their guidelines, including weak evidence paired with strong recommendations and failure to conduct proper systematic reviews of treatment outcomes.
- Systematic reviews by Sweden, Finland, the UK's NICE, and Florida's health agency all concluded that evidence for puberty blockers, hormones, and surgeries in minors is inconclusive, insufficient, or of very low quality—directly contradicting claims of scientific certainty.
- The number of young people discontinuing hormone treatment may be as high as 20-30% within a few years, and 'detransitioners' are increasingly speaking out about harms from early medical interventions that they say were not truly informed consent.
- Clinical practice has shifted rapidly toward faster medicalization, with some teens receiving hormones within 12 months of their first clinic visit and mental health evaluations being de-emphasized, raising concerns about inadequate assessment of whether gender dysphoria will persist.
Detransicija potrebuje več razumevanja, ne polemik(2023)
Kinnon Ross MacKinnon, Pablo Expósito-Campos, W Ariel Gould (BMJ)
mental healthdetransitionmedical ethicsgender dysphoriaqualitative researchgender-affirming care
Ta članek trdi, da so raziskovalci in kliniki detransicijo spregledali, kar je povzročilo neizpolnjene zdravstvene potrebe. Avtorji pozivajo k trdnim, nepolitiziranim raziskavam za razumevanje raznolikih izkušenj tistih, ki prenehajo s spolno prehodnostjo, in opozarjajo, da so sedanje študije omejene s kratkimi obdobji spremljanja in izbirno pristranskostjo. Poudarjajo, da je izboljšanje oskrbe za tiste, ki prenehajo s spolno prehodnostjo, nujen del celovite oskrbe spola in bo na koncu koristilo vsem trans osebam, saj bo omogočilo boljše razumevanje dolgoročnih rezultatov.
www.bmj.com/content/381/bmj-2022-073584Key Findings
- Detransition is poorly understood due to limited research and stigma, leaving people with unmet healthcare needs and no clinical guidelines for care.
- People who detransition are diverse: many are female, transitioned young, and may re-identify with their birth sex, sexual orientation, or continue identifying as trans.
- Common reasons for detransition include persistent or returning gender dysphoria, health concerns, social discrimination, identity exploration, or unresolved dysphoria despite treatment.
- Research on detransition needs major improvements: longer follow-up periods (5-10 years), using patients' preferred language, and including those lost to follow-up to avoid biased conclusions.
- Trans and detrans people share more similarities than differences; studying detransition benefits all gender-diverse individuals and strengthens comprehensive gender care for everyone.
Žalost zaradi dojenja po mastektomiji za moško oblikovanje prsnega koša in detransformaciji(2023)
Karleen D. Gribble, Susan Bewley, Hannah G. Dahlen (Frontiers in Global Women's Health)
detransitionmedical ethicsgender dysphoriaqualitative researchsurgeriescase report
Ta študija primera podrobno opisuje izkušnjo ženske, ki je opustila spolno preobrazbo in je po mastektomiji za moško oblikovanje prsnega koša zanosila ter doživela globoko žalost in psihično stisko zaradi nezmožnosti dojenja. Poročilo poudarja pomanjkanje informirane privolitve glede izgube funkcije dojenja, slabo razumevanje zdravstvenih delavcev in čustveno breme matere.
www.frontiersin.org/articles/10.3389/fgwh.2023.1073053/fullKey Findings
- Breastfeeding is rarely discussed in counseling or consent guidelines for chest masculinization mastectomy, despite the procedure often permanently destroying the ability to produce and deliver milk.
- A detransitioned woman experienced intense grief over her inability to breastfeed, compounded by maternity providers who dismissed her distress or misgendered her due to inadequate training on detransition.
- The most common chest masculinization surgical technique—free nipple grafting—almost certainly precludes breastfeeding, yet existing literature falsely claims outcomes cannot be predicted.
- Research on detransition rates and long-term outcomes of chest masculinization surgery is poor quality, with short follow-up periods and high loss to follow-up that may underestimate regret.
- Health providers need individualized, sex-based care for detransitioned women, including emotional support for breastfeeding grief, donor milk access, and avoidance of assumptions about gender identity.
Nadaljevanje spolno potrjevalnih hormonov pri transspolnih mladostnikih in odraslih(2022)
Christina M. Roberts, David A. Klein, Terry A. Adirim, Natasha A. Schvey, Elizabeth Hisle-Gorman (The Journal of Clinical Endocrinology & Metabolism)
cohort studytransition outcomesmedical ethicsgender dysphoriagender-affirming careadolescent
Ta študija 952 posameznikov v sistemu vojaškega zdravstva ZDA je spremljala stopnje nadaljevanja/prekinitve uporabe križnih spolnih hormonov. Medtem ko je približno 70 % nadaljevalo uporabo hormonov vsaj 4 leta, je bila stopnja prekinitve (opustitev) 30 % – bistveno višja pri transmaskulinih posameznikih (35,6 % prekinitve) v primerjavi s transfemininimi (19 %). Odrasli, ki so začeli jemati hormone po 18. letu starosti, so imeli stopnjo prekinitve 35,6 %. Omeniti velja, da je skoraj 26 % (1 od 4) tistih, ki so začeli kot mladoletniki, prekinilo zdravljenje. Te ugotovitve kažejo, da so lahko stopnje opustitve višje od tistih, ki so običajno navedene v literaturi, in razkrivajo pomembne razlike glede na spol in starost ob začetku.
academic.oup.com/jcem/article/107/9/e3937/6572526Key Findings
- 70% continuation rate at 4 years — roughly 3 in 10 people stopped filling hormone prescriptions within the study period.
- Transfeminine patients continued at higher rates (81%) than transmasculine patients (64%) — females seeking masculinization were 2.4 times more likely to discontinue.
- Minors had higher continuation (74%) than adults (64%) — those who started before 18 were less likely to stop.
- Socioeconomic factors showed no effect — family income, parental military rank, and whether care was officially covered didn't influence continuation rates.
- The study only tracked prescription refills, not reasons or outcomes — continuation does not indicate satisfaction, and the authors could not determine why people stopped.
Potrebe in podpora, povezane z detranzicijo: presečna spletna anketa(2022)
Elie Vandenbussche (Journal of Homosexuality)
mental healthdetransitiongender dysphoriaautismgender-affirming carecross-sectional surveysocial support
Ta spletna anketa med 237 osebami, ki so detranzicionirale (92 % žensk), je pokazala pomembne nezadovoljene potrebe. Ključni razlogi za detranzicijo so vključevali spoznanje, da je bila disforija povezana z drugimi težavami (70 %), zdravstvene skrbi (62 %) in to, da tranzicija ni pomagala pri disforiji (50 %). Med glavne potrebe so sodile psihološka podpora pri komorbidnih stanjih in obžalovanju, medicinska pomoč pri zapletih ter socialna povezanost z drugimi osebami, ki so detranzicionirale. Mnogi so poročali o pomanjkanju podpore, negativnih izkušnjah z zdravstvenimi delavci in zavrnitvi s strani LGBT skupnosti.
www.tandfonline.com/doi/full/10.1080/00918369.2021.1919479Key Findings
- Detransitioners report significant unmet psychological needs, including coping with gender dysphoria, comorbid mental health conditions, feelings of regret, and internalized homophobia or sexism.
- Many detransitioners need medical support for stopping or changing hormone therapy, dealing with surgery complications, and accessing reversal procedures, but often face dismissive or uninformed healthcare providers.
- Social connection with other detransitioners is critical—87% wanted to hear others' stories and 76% wanted direct contact—yet many experience isolation and rejection from LGBT+ communities they previously belonged to.
- A large majority (70%) realized their gender dysphoria was related to other underlying issues, and half found that transition did not alleviate their dysphoria, highlighting the need for alternative treatment approaches.
- Overall support for detransitioners is severely lacking: only 18% felt they received enough support, with many reporting negative experiences with medical systems, mental health professionals, and loss of community ties.
Pregled športnih prednosti(2022)
Pigozzi et al (BMJ Open Sport & Exercise Medicine)
medical ethicsgender identitysports medicinetestosteronefairnessinclusiontransgender athletesdifferences of sexual development
Pregled študij, ki kažejo, da transspolne ženske obdržijo 9-31 % prednosti v mišični masi, moči in hemoglobinu po hormonski terapiji zaradi nepopravljivih učinkov moške pubertete.
www.insidethegames.biz/articles/1117938/ioc-transgender-framework-criticisedKey Findings
- The 2021 IOC framework on gender identity and sex variations is criticized for prioritizing human rights perspectives over medical and scientific evidence, particularly its stance of 'no presumption of advantage' regarding testosterone levels.
- Testosterone is well-established as a performance-enhancing hormone that increases muscle mass and athletic ability, and the authors argue that high testosterone concentrations confer a baseline competitive advantage that must be recognized and mitigated.
- The framework places full responsibility for gender eligibility rules on International Federations (IFs), most of which lack the capacity, resources, and expertise to implement it effectively.
- The authors warn that implementation could lead to two undesirable extremes: either total exclusion of transgender and DSD athletes from competition, or self-identification policies that effectively eliminate meaningful eligibility rules and fair competition.
- The position statement calls for the IOC to provide clear, evidence-based standards for all sports to follow, rather than leaving individual federations to navigate this complex issue alone.
Oskrba transspolnih pacientov: Pristop k izboljšanju kakovosti v splošni praksi(2022)
Isabel Boyd, Thomas Hackett, Susan Bewley (Healthcare)
cohort studydetransitionmedical ethicsgender dysphoriagender-affirming careprimary carequality improvement
Revizija primarnega zdravstvenega varstva v Združenem kraljestvu 68 transspolnih pacientov ni odkrila doslednih nacionalnih smernic za spremljanje, kar je privedlo do podstandardne oskrbe do dveh tretjin pacientov. Študija je razkrila dolge čakalne dobe za specializirane storitve, visoke stopnje sočasnih duševnih zdravstvenih težav in 20-odstotno stopnjo prekinitve hormonskega zdravljenja, pri čemer je več kot polovica tistih, ki so prenehali, navedla detransicijo ali obžalovanje. Avtorji pozivajo k standardom primarnega zdravstvenega varstva, ki temeljijo na dokazih.
www.mdpi.com/2227-9032/10/1/121Key Findings
- No UK-wide or international primary care guidelines exist for transgender healthcare, and existing guidance from gender identity clinics is often contradictory, making quality care difficult to deliver.
- Up to two-thirds of transgender patients in the audit did not receive all recommended monitoring standards, largely due to conflicting instructions between different gender identity clinics and international guidelines.
- A significant portion of patients (20%) stopped hormone therapy, with more than half of those citing regret or detransition experiences—raising concerns about current assessment and treatment approaches.
- Patients faced long waits for gender identity clinic appointments (averaging 26 months) and high rates of co-existing mental health conditions, including anxiety, depression, self-harm, and autism spectrum disorder.
- The authors call for urgent development of evidence-based, standardized primary care guidelines with measurable quality standards, and recommend this audit approach be replicated nationally to improve understanding of patient outcomes.
Spolna detranzicija: Študija primera(2021)
Lisa Marchiano (Journal of Analytical Psychology)
detransitiontraumagender exploratory therapycountertransferencegender dysphoriagender-affirming carecase reportadolescent
Ta študija primera mlade odrasle ženske, ki je prestala tranzicijo, poudari kompleksnost razvoja spolne identitete. Pacientka je imela zgodovino travme, avtizma in komorbiditet duševnega zdravja. Avtor poudari potrebo po temeljiti psihološki oceni in previdnem, individualiziranem pristopu za mlade s spolno disforijo, ki omogoča raziskovanje identitete brez prezgodnje medicinizacije.
onlinelibrary.wiley.com/doi/10.1111/1468-5922.12711Key Findings
- A sharp global rise in adolescents identifying as transgender has been accompanied by increasing numbers of young people detransitioning, particularly natal females.
- The case study of Maya illustrates how gender dysphoria can sometimes reflect unaddressed psychological issues—such as unmetabolized grief, attachment trauma, and family dynamics—rather than a core transgender identity.
- The author critiques the gender affirmative model of care for potentially concretizing distress and foreclosing deeper psychological exploration by immediately affirming a patient's stated gender identity.
- Maya's trans identification served multiple unconscious functions: rejecting her mother, escaping feminine expectations, expressing split-off aggression, and gaining social belonging, while her detransition allowed therapeutic work on these underlying issues.
- The paper argues for psychotherapeutic approaches that maintain symbolic thinking about gender distress and help patients confront bodily and emotional reality, rather than rushing to medical interventions.
Dostop do oskrbe in pogostnost detransicije v kohorti, ki jo je odpustila britanska nacionalna klinika za spolno identiteto odraslih: retrospektivni pregled zapisov o primerih(2021)
R. Hall, L. Mitchell, J. Sachdeva (BJPsych Open)
mental healthcohort studydetransitiontraumagender dysphoriagender-affirming careadolescent
Od 175 odraslih, ki so bili odpusteni iz britanske klinike za spolno identiteto, je le 56% zaključilo načrtovano pot; 59% je dobilo vse želene obravnave (94% hormoni, 48% operacija). 22% je opustilo, 19% je bilo kmalu ponovno napotenih. Nevrorazvojni pogoji, otroške stiske, tekoči problemi z duševnim zdravjem ali substancami so napovedovali slabše rezultate. Avtorji pozivajo k bolj individualizirani, travmoinformirani oskrbi.
www.cambridge.org/core/journals/bjpsych-open/article/access-to-care-and-frequency-of-detransition-among-a-cohort-discharged-by-a-uk-national-adult-gender-identity-clinic-retrospective-casenote-review/3F5AC1315A49813922AAD76D9E28F5CBKey Findings
- Only 56% of patients completed their planned treatment pathway, with 22% disengaging from care entirely and 19% being re-referred shortly after discharge.
- Hormone therapy was accessed by 94% of those who sought it, but gender reassignment surgery rates were much lower—57% for feminizing and just 26% for masculinizing procedures.
- Four factors were independently linked to worse outcomes: neurodevelopmental disorders, adverse childhood experiences, substance misuse during treatment, and mental health concerns during treatment.
- The detransition rate of 6.9% is notably higher than previously reported UK figures, though the authors note this may still be an underestimate due to limited follow-up time.
- The study raises concerns about implementing streamlined care models uniformly, given the significant heterogeneity and complex needs of patients accessing gender identity services.
Sledilna študija fantov z motnjo spolne identitete(2021)
Devita Singh, Susan J. Bradley, Kenneth J. Zucker (Frontiers in Psychiatry)
cohort studytransition outcomesdetransitiongender dysphoriagender identity disordersexual orientationchildhooddesistancepersistence
Ta študija poroča o podatkih sledenja največjemu vzorcu do zdaj fantov, klinično napotenih zaradi spolne disforije (n=139). V otroštvu so bili fantje ocenjeni v povprečni starosti 7,49 let in sledeni v povprečni starosti 20,58 let. Od 139 fantov jih je bilo 17 (12,2%) razvrščenih kot vztrajajoči in 122 (87,8%) kot nehajoči. Podatki so pokazali, da so imeli fantje, klinično napoteni zaradi skrbi glede spolne identitete, visoko stopnjo nehajanja in visoko stopnjo bifilne/androfilne spolne usmerjenosti.
www.frontiersin.org/articles/10.3389/fpsyt.2021.632784/fullKey Findings
- Of 139 boys clinic-referred for gender dysphoria in childhood, only 12.2% (17) persisted with gender dysphoria into adolescence/adulthood, while 87.8% (122) desisted.
- A large majority of boys in the study developed a biphilic/androphilic (same-sex attracted) sexual orientation: 63.6% in fantasy and 47.2% in behavior, with an additional quarter reporting no sexual behaviors.
- Boys who persisted with gender dysphoria tended to be older at childhood assessment, from lower social class backgrounds, and showed more severe gender-variant behavior in childhood compared to desisters.
- The study found no significant difference in persistence rates between boys who met full diagnostic criteria for gender identity disorder in childhood (13.6%) versus those who were subthreshold (9.8%).
- The authors note this is the largest follow-up study of its kind and discuss implications for contemporary treatment approaches, particularly the increasing practice of early social gender transition which was rare in their sample.
Posamezniki, zdravljeni zaradi spolne disforije z medicinskim in/ali kirurškim prehodom, ki so pozneje prenehali s prehodom: Raziskava med 100 osebami(2021)
Lisa Littman (Archives of Sexual Behavior)
mental healthdetransitiontraumamedical ethicsgender dysphoriarapid-onset gender dysphoriasurvey
Ta raziskava med 100 osebami, ki so prenehale s spolno prehodom (69% žensk), je odkrila različne razloge za prekinitev, vključno z večjim udobjem s svojim spolom ob rojstvu (60%), zaskrbljenostjo zaradi zdravstvenih zapletov (49%) in spoznanjem, da je njihova disforija povezana z drugimi težavami, kot so travme ali stanja duševnega zdravja (38%). Omeniti velja, da je 23% navedlo homofobijo ali težave pri sprejemanju privlačnosti do istega spola kot dejavnik. Večina (55%) je menila, da je bila njihova začetna ocena za prehod nezadostna, in le 24% je obvestilo svoje zdravnike o prekinitvi.
pubmed.ncbi.nlm.nih.gov/34665380/Key Findings
- Most detransitioners (69%) were natal females, and the most common reason for detransitioning was becoming more comfortable identifying as their natal sex (60%), not external discrimination.
- A majority (55%) felt they did not receive adequate evaluation from doctors or mental health professionals before starting transition, and nearly half said counseling was overly positive about benefits while downplaying risks.
- Many participants attributed their gender dysphoria to underlying factors such as trauma, mental health conditions (38%), or internalized homophobia (23%), suggesting alternative causes were not fully explored beforehand.
- Social media and online communities played a significant role in encouraging transition, with YouTube videos (48%), blogs (46%), and Tumblr (45%) being major influences; 20% felt socially pressured to transition by friends, partners, or clinicians.
- Only 24% of detransitioners informed their clinicians that they had detransitioned, indicating that official clinic rates likely underestimate the true prevalence of this outcome.
Tipologija spolne detranzicije in njen pomen za ponudnike zdravstvenih storitev(2021)
Pablo Expósito-Campos (Journal of Sex & Marital Therapy)
mental healthdetransitionmedical ethicsgender dysphoriaqualitative researchautismgender-affirming care
Ta študija predlaga prvo sistematično tipologijo spolnega detranzicioniranja za reševanje neskladnosti v tem, kako so koncept uporabljali kliniki in raziskovalci. Tipologija razvršča detranzicioniranje glede na to, ali posamezniki po prenehanju s prehodnimi posegi prenehajo ali nadaljujejo z identificiranjem kot transseksualci. Avtor discusses implikacije za zdravstvene delavce in poudarja potrebo po kliničnih smernicah specifično za detranzicioniste. Članek prav tako raziskuje možnosti za preprečevanje detranzicioniranja in izpost vlja izzive, s katerimi se kliniki soočajo pri zdravljenju posameznikov s spolno disforijo. Zaključuje, da je detranzicioniranje nov, a slabo razumljen pojav, ki zahteva specializirano zdravstveno podporo nadaljnje raziskave.
pubmed.ncbi.nlm.nih.gov/33427094/Key Findings
- The paper proposes a new typology distinguishing 'core' detransition (driven by reidentification with birth sex) from 'non-core' detransition (stopping transition while still identifying as transgender due to external pressures or health concerns).
- Healthcare providers should not rely solely on patient self-identification for clinical decisions, as identities can be fluid; comprehensive psychological assessments and differential diagnosis remain essential.
- Clinicians need to provide honest, transparent communication about the benefits, risks, and limitations of gender-affirming treatments to ensure meaningful informed consent.
- Core and non-core detransitioners have different healthcare needs, requiring tailored clinical guidelines—core detransitioners need help coping with dysphoria without medical transition, while non-core detransitioners may need support for discrimination or medical complications.
- Detransition should not be viewed as automatic 'failure' or 'regret'; clinicians must adopt non-judgmental, compassionate approaches with regular long-term follow-ups for all patients.
- Some individuals initially detransition to non-binary identities before fully reidentifying with their birth sex, suggesting non-binary identification can function as a stepping-stone rather than endpoint.
- The paper notes elevated rates of autism spectrum traits among core detransitioners, possibly linked to intense or obsessional interests around gender. This co-occurrence warrants careful clinical screening rather than automatic affirmation.
Nujna potreba po raziskavah in storitvah za spolne desisterje /detransicionerje(2020)
Butler, C. & Hutchinson, A.
mental healthdetransitiongender dysphoriaadolescentdesistanceclinical implicationsresearch gaps
Ta članek poudarja naraščajoče število posameznikov, ki si prizadevajo prenehati ali se vrniti iz spolnega prehoda. Avtorji trdijo, da kljub temu trendu obstaja pomembno pomanjkanje raziskav, kliničnih smernic in podpore za to populacijo. Ugotavljajo, da medtem ko obstajajo obsežni protokoli za prehod, ni nobenih za tiste, ki se vrnejo, in pozivajo k nujni pozornosti kliničnim in raziskovalnim potrebam te skupine.
acamh.onlinelibrary.wiley.com/doi/abs/10.1111/camh.12361Key Findings
- Desisters and detransitioners—people who stop or reverse gender transitions—exist but are often overlooked in research and clinical care, with no established protocols to support them.
- Reported desistance rates vary dramatically (from 73% to 98% in children), but current data is unreliable due to changing diagnostic criteria, sampling biases, short follow-up periods, and a rapidly evolving patient population.
- Today's gender clinic patients differ significantly from past cohorts: there are far more adolescents, more assigned-female-at-birth patients, more non-binary individuals, more who have already socially transitioned, and more with co-occurring conditions like autism or mental health issues.
- Common factors associated with desistance include lower intensity gender dysphoria, greater body acceptance, resolution of contributing issues like homophobic bullying or family difficulties, and eventual gay or lesbian identity.
- Clinical care should be non-judgmental, view gender and sexual identity as potentially fluid, address social context and support systems, connect people to peer groups, and ensure access to medical professionals who can help reverse prior interventions when needed.